Vietnam-made drug reduces cancer treatment costs by 60 percent
The made-in-Vietnam drug pegfilgrastim is expected to be available in the first quarter of 2018, helping reduce cancer treatment costs by up to 60 percent compared with imported drugs.
Hanoi (VNA) – The made-in-Vietnamdrug pegfilgrastim isexpected to be available in the first quarter of 2018, helping reduce cancertreatment costs by up to 60 percent compared with imported drugs, according tothe Ministry of Science and Technology. Pegfilgrastimis a product of the national programme on high technology development, implementedby thebiotechnology and pharmacy firm Nanogen in 2014. Pegfilgrastim, which boosts white bloodcells and supports the immune system, is used in chemotherapy and radiationtherapy. Nanogen plans to produce 120,000 tubes ofthe drug (6 mg per tube) which meet European standards. The company has so farcompleted the drug production procedures and tests of the drug quality in thelaboratory and on animals, while clinical trials have also been conducted.-VNA
With the adoption of cutting-edge technology at a comparatively low cost, Professor Mai Trong Khoa at Bach Mai Hospital - and colleagues have saved many cancer patients “at death’s door”.
Nearly 300 professors, doctors and leading oncologists have gathered in central Da Nang city to take part in a national conference on cancer prevention and control which opened on April 27.
The Vietnam Medical Association and Cancer Patients Assistance Fund “For a Brighter Future” and the Cancer Research Institute put up 50 bookshelves in Hanoi-based K Hospital on August 9.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
A cancer patient under treatment (Source: VNA) 
